Lexogen Receives FFG Funding to Develop a Novel SARS-CoV-2 Test for Mass Screening

By |2020-04-29T12:01:28+02:00April 29th, 2020|News, Press release|

Vienna, Austria, April 29, 2020 – Lexogen GmbH, a Vienna based Next-Generation Sequencing (NGS) and transcriptomics company, receives funding from [...]